From: Identification of lung cancer with high sensitivity and specificity by blood testing
Classification task | Accuracy % | Sensitivity % | Specificity % |
---|---|---|---|
lung cancer vs controls | 97.6 (CI: 97.3-97.9) | 97.9 (CI: 96.6-97.8) | 97.0 (CI:97.6-98.3) |
lung cancer stage IA/IB vs controls | 92.9 (CI: 92.4-93.4) | 75.9 (CI: 73.7-78.2) | 97.6 (CI: 97.3-97.8) |
lung cancer stage II, III, IV vs controls | 97.6 (CI: 97.1-98.0) | 99.9 (CI: 87.2-91.0) | 89.1 (CI: 99.7-100.0) |
lung cancer stage IA/IB vs lung cancer stage II, III, IV | 66.5 (CI: 63.8-69.1) | 65.7 CI: 62.2-69.2) | 67.3 (CI: 64.6-70.0) |
NSCLC vs controls | 94.6 (CI: 93.9-95.2) | 97.8 (CI: 97.5-98.2) | 85.7 (CI: 83.8-87.5) |
SCLC vs controls | 95.7 (CI: 95.2-96.0) | 99.3 (CI: 99.0-99.6) | 79.4 (CI: 77.5-81.4) |
NSCLC vs SCLC | 67.3 (CI: 65.4-69.3) | 76.7 (CI: 74.4-79.0) | 52.2 (CI: 50.0-54.4) |
lung cancer vs NTLP | 88.5 (CI: 88.0-89.3) | 99.8 (CI: 99.5-100.0) | 42.4 (CI: 40.2-44.6) |
lung cancer vs non-cancer | 92.2 (CI: 91.6-92.9) | 96.7 (CI: 95.5-97.9) | 88.2 (CI: 87.5-88.8) |
lung cancer vs COPD/emphysema | 78.8 (CI: 78.0-79.7) | 92.6 (CI: 91.6-93.5) | 40.9 (CI: 38.8-43.0) |